Prostate cancer (PCa), the second most common cancer and the fifth dominating cause of cancer-specific mortality among men around the world [1, 2], has been increasingly discovered due to the widespread diffusion of prostate-specific antigen (PSA) screening, markedly the localized ones [3–5]. Here, KLK3 is linked to cancer.